Also, Beate Christiane Schlueter’s article revealed that levels of the protein known as IGFBP-2 were elevated in patients diagnosed with PAH in comparison to individuals deemed to be healthy. This evidence concerns the gene IGFBP2 and pulmonary arterial hypertension.